Bristol Myers Squibb in an all-cash deal at $5 per share, with the merger set to close in Q2 2025. Despite Abecma generating $242 million in U.S. sales, 2seventy still booked a $3.3 million loss from ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Shares of Bristol Myers Squibb Co. slid 3.05% to $59.19 Tuesday, on what proved to be an all-around favorable trading session ...

"It’s as much of the marquee high-value transactions as it is the aggregation of what we call our bread and butter, and it’s ...

Bearish flow noted in Bristol Myers ( BMY) Squibb with 13,765 puts trading, or 2x expected. Most active are Apr-25 60 puts and 4/4 weekly 60 puts, with total volume in those strikes near 8,600 ...

BMY has enjoyed robust capital appreciation over the past few months, significantly aided by the ongoing market rotation to ...

After every meal, the intestines perform an action called peristalsis - moving food through their hollow interiors with coordinated contractions and relaxations of the smooth muscle.

We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look ...

Research in mice identifies protein responsible for regulating gut movement in response to pressure, exercise, and ...

But what it does have is its critical role—albeit underrated—as a biotech hub. Competing with South San Francisco and Boston, ...

Jiangsu Hengrui Pharmaceuticals and its partner Elevar Therapeutics will have to wait even longer before their PD-1 inhibitor ...